Organoids Services Market Analysis and Growth - 2031
Organoids Services Market Report Scope
Report Attribute | Details |
---|---|
Market size in 2023 | US$ 3.03 Billion |
Market Size by 2031 | US$ 15.01 Billion |
Global CAGR (2023 - 2031) | 22.3% |
Historical Data | 2021-2022 |
Forecast period | 2024-2031 |
Segments Covered |
By Type
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
Organoids Services Market News and Recent Developments
The organoids services market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the market are listed below:
- InSphero, a biotech company, signed a partnership agreement with Genome Biologics, Frankfurt. In this partnership, InSphero will receive the exclusive global rights to commercialize Genome Biologics' 3D Cardiac Organoid Platform. The platform provides accurate, scalable, and disease-specific organoid models for creating novel treatments, placing it at the forefront of heart disease research. (InSphero, Press Release, May 2024)
Organoids Services Market Report Coverage and Deliverables
The "Organoids Services Market Size and Forecast (2021–2031)" report provides a detailed analysis of the market covering below areas:
- Organoids services market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Organoids services market trends as well as market dynamics such as drivers, restraints, and key opportunities
- Detailed PEST/Porter's Five Forces and SWOT analysis
- Organoids services market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments.
- Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the organoids services market
- Detailed company profiles